PMS56 - COST-EFFECTIVENESS ANALYSIS OF SUBCUTANEOUS TOCILIZUMAB WITHOUT METHOTREXATE IN RHEUMATOID ARTHRITIS TREATMENT
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.1770
https://www.valueinhealthjournal.com/article/S1098-3015(18)35072-1/fulltext
Title :
PMS56 - COST-EFFECTIVENESS ANALYSIS OF SUBCUTANEOUS TOCILIZUMAB WITHOUT METHOTREXATE IN RHEUMATOID ARTHRITIS TREATMENT
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35072-1&doi=10.1016/j.jval.2018.09.1770
First page :
Section Title :
Open access? :
No
Section Order :
1134